AVITA Medical (RCEL) Net Income Growth (1y) (2019 - 2025)
AVITA Medical (RCEL) Net Income Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn | -30.10% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn | 125.69% |
| 10 | AVITA Medical | 132.76 Mn | 116.42 Mn | 14.31 Mn | 87.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 87.83% |
| Sep 30, 2025 | 18.62% |
| Jun 30, 2025 | 35.56% |
| Mar 31, 2025 | 25.72% |
| Dec 31, 2024 | -63.85% |
| Sep 30, 2024 | -86.01% |
| Jun 30, 2024 | -48.24% |
| Mar 31, 2024 | -102.36% |
| Dec 31, 2023 | -133.00% |
| Sep 30, 2023 | -55.91% |
| Mar 31, 2023 | 2.57% |
| Sep 30, 2022 | 66.46% |
| Mar 31, 2022 | -57.80% |
| Sep 30, 2021 | -62.93% |
| Jun 30, 2021 | 17.03% |
| Mar 31, 2021 | 60.15% |
| Dec 31, 2020 | 46.29% |
| Sep 30, 2020 | -186.79% |
| Mar 31, 2020 | -143.42% |
| Dec 31, 2019 | -67.60% |